Research ArticleArticle
Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis
Linda A. Bradbury, Kelly A. Hollis, Benoît Gautier, Sateesh Shankaranarayana, Philip C. Robinson, Nivene Saad, Kim-Anh Lê Cao and Matthew A. Brown
The Journal of Rheumatology February 2018, jrheum.170312; DOI: https://doi.org/10.3899/jrheum.170312
Linda A. Bradbury
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Kelly A. Hollis
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Benoît Gautier
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Sateesh Shankaranarayana
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Philip C. Robinson
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Nivene Saad
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Kim-Anh Lê Cao
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Matthew A. Brown
From the Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital; University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; Royal Brisbane and Women’s Hospital; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia. The study was funded by a grant from Abbvie Australia. MAB is funded by an Australian National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. KALC is supported by an NHMRC Career Development Fellowship (APP1087415). The funding bodies had no role in the design, collection, analysis, or interpretation of this study. L.A. Bradbury, MSc, MNPSt, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; K.A. Hollis, BScN, RN, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute; B. Gautier, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; S. Shankaranarayana, MBBS, PhD, Princess Alexandra Hospital; P.C. Robinson, PhD, FRACP, Royal Brisbane and Women’s Hospital; N. Saad, MD, FRANZCR, Princess Alexandra Hospital; K.A. Lê Cao, PhD, University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital; M.A. Brown, MD, PhD, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology at Translational Research Institute. Address correspondence to Prof. M.A. Brown, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia. E-mail: Matt.brown@qut.edu.au. Accepted for publication November 7, 2017.
Article Figures & Data
Additional Files
Data Supplement
Files in this Data Supplement:
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis
Linda A. Bradbury, Kelly A. Hollis, Benoît Gautier, Sateesh Shankaranarayana, Philip C. Robinson, Nivene Saad, Kim-Anh Lê Cao, Matthew A. Brown
The Journal of Rheumatology Feb 2018, jrheum.170312; DOI: 10.3899/jrheum.170312
Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis
Linda A. Bradbury, Kelly A. Hollis, Benoît Gautier, Sateesh Shankaranarayana, Philip C. Robinson, Nivene Saad, Kim-Anh Lê Cao, Matthew A. Brown
The Journal of Rheumatology Feb 2018, jrheum.170312; DOI: 10.3899/jrheum.170312